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Abstract
Background: Helicobacter pylori is a gram-negative bacterium that colonizes the human stomach and contributes
to the development of gastric cancer and peptic ulcer disease. VacA, a toxin secreted by H. pylori, is comprised of
two domains, designated p33 and p55. Analysis of the crystal structure of the p55 domain indicated that its
structure is predominantly a right-handed parallel b-helix, which is a characteristic of autotransporter passenger
domains. Substitution mutations of specific amino acids within the p33 domain abrogate VacA activity, but thus
far, it has been difficult to identify small inactivating mutations within the p55 domain. Therefore, we hypothesized
that large portions of the p55 domain might be non-essential for vacuolating toxin activity. To test this hypothesis,
we introduced eight deletion mutations (each corresponding to a single coil within a b-helical segment spanning
VacA amino acids 433-628) into the H. pylori chromosomal vacA gene.
Results: All eight of the mutant VacA proteins were expressed by the corresponding H. pylori mutant strains and
underwent proteolytic processing to yield ~85 kDa passenger domains. Three mutant proteins (VacA Δ484-504,
Δ511-536, and Δ517-544) were secreted and induced vacuolation of mammalian cells, which indicated that these
b-helical coils were dispensable for vacuolating toxin activity. One mutant protein (VacA Δ433-461) exhibited
reduced vacuolating toxin activity compared to wild-type VacA. Other mutant proteins, including those containing
deletions near the carboxy-terminal end of the b-helical region (amino acids Val
559-Asn
628), exhibited marked
defects in secretion and increased susceptibility to proteolytic cleavage by trypsin, which suggested that these
proteins were misfolded.
Conclusions: These results indicate that within the b-helical segment of the VacA p55 domain, there are regions
of plasticity that tolerate alterations without detrimental effects on protein secretion or activity, as well as a
carboxy-terminal region in which similar alterations result in protein misfolding and impaired secretion. We
propose that non-essential b-helical coils and a carboxy-terminal b-helical segment required for proper protein
folding and secretion are features shared by numerous autotransporter passenger domains.
Background
Numerous bacterial pathogens secrete virulence factors
b yat y p eV( a u t o t r a n s p o r t e r ) pathway [1]. Crystallo-
graphic studies of three passenger domains secreted by
a classical (type Va) autotransporter pathway revealed
that each has a predominantly b-helical structure [2-4],
and it is predicted that nearly all autotransporter pas-
senger domains share a b-helical fold [5]. Very little is
known about the structural features that are responsible
for the unique properties of individual autotransporter
passenger domains.
The Helicobacter pylori VacA toxin is one of the most
extensively studied bacterial proteins secreted by a classi-
cal autotransporter pathway [6-9]. VacA is classified as a
pore-forming toxin, but unlike many other bacterial pore-
forming toxins, VacA is internalized by cells and can cause
cellular alterations by acting intracellularly [6,7,10]. VacA
causes a wide array of alterations in mammalian cells,
including cell vacuolation, mitochondrial alterations, and
plasma membrane permeabilization [6,8], and targets a
variety of cell types, including gastric epithelial cells [11],
T cells [12,13], and mast cells [14,15]. Several lines of evi-
dence suggest that VacA contributes to the development
of H. pylori-associated peptic ulcer disease and gastric ade-
nocarcinoma in humans [6,11,16-18].
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which undergoes proteolytic processing to yield a 33-
amino acid signal sequence, a mature 88 kDa secreted
toxin, a ~12 kDa secreted peptide, and a carboxy-term-
inal domain that remains associated with the bacteria
[18-20]. The mature 88 kDa VacA passenger domain
can be proteolytically processed into an amino-terminal
33 kDa (p33) fragment and a carboxy-terminal 55 kDa
(p55) fragment [21], which are considered to represent
two domains or subunits of VacA [18,22,23] (Fig. 1A).
When expressed intracellularly in eukaryotic cells, about
422 residues at the amino-terminus of VacA (compris-
ing the p33 domain and part of the p55 domain) are
sufficient to cause cell vacuolation [24]. Previous studies
have shown that the amino-terminal hydrophobic por-
tion of the p33 domain has an important role in
membrane channel formation [24-27]. Components of
both the p33 domain and the p55 domain are required
for VacA oligomerization [3,28,29], and components of
the p55 domain are required for VacA binding to host
cells [22,30,31].
Recently the crystal structure of the p55 domain of a
VacA protein was determined [3]. The most striking fea-
ture of this domain is the presence of a right-handed
parallel b-helical structure, composed of coiled, parallel
b-sheet structures (Fig. 1B). Each coil of the parallel b-
helix consists of three parallel b-strands connected by
loops of different lengths. The b-helical portion of the
VacA p55 domain of H. pylori strain 60190 consists of
about 13 coils (Fig. 1B) [3]. Substitution mutagenesis of
single amino acids within the amino-terminal region of
the p33 domain is sufficient to ablate multiple activities
Figure 1 Introduction of deletion mutations into the VacA p55 domain. (A) Diagram of the full-length 88 kDa VacA protein secreted by H.
pylori strain 60190 [19]. p33 (amino acids 1 to 311) and p55 (amino acids 312-821) domains are shown. Mutations encoding single coil deletions
within the b-helix of the p55 domain were introduced into the H. pylori chromosomal vacA gene by natural transformation and allelic exchange
as described in Methods. The relative position of each single coil deletion is shown. (B) Crystal structure of the p55 VacA domain of H. pylori
strain 60190 [3]. The sites of two coils targeted for deletion mutagenesis (amino acids 433-461 and 608-628) are highlighted in red.
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identify small inactivating mutations within the p55
domain [26]. The only known small inactivating muta-
tion within the p55 domain is a deletion of two amino
acids (aspartic acid 346 and glycine 347, located in a
region of the p55 domain not included in the crystal
structure) [29,32], which results in defective oligomeri-
zation of VacA.
Since it has been difficult to identify small inactivating
mutations within the p55 domain [26], we hypothesized
that large portions of the p55 domain might be non-
essential for vacuolating toxin activity. To test this
hypothesis, in the current study we generated a set of H.
pylori mutant strains expressing VacA proteins in which
individual coils of the p55 b-helix were deleted, and we
then analyzed the secretion and activity of these mutant
proteins. We report that within the VacA b-helix, there
are regions of plasticity that tolerate alterations without
detrimental effects on protein secretion or activity, as
well as a carboxy-terminal region in which similar
alterations result in impaired secretion and protein
misfolding.
Methods
H. pylori strains and growth conditions
H. pylori wild-type strain 60190 (ATCC 49503) was the
parent strain used for construction of all mutants in this
study. The sequence of the VacA protein encoded by
this strain is deposited as GenBank accession number
Q48245. Throughout this study, we use an amino acid
numbering system in which residue 1 refers to alanine 1
of the secreted 88 kDa VacA protein, and the p55
domain corresponds to amino acids 312 to 821. H.
pylori strains were grown on trypticase soy agar plates
containing 5% sheep blood at 37°C in ambient air con-
taining 5% CO2. H. pylori liquid cultures were grown in
sulfite-free Brucella broth containing 10% fetal bovine
serum (BB-FBS).
Introduction of deletion mutations into the chromosomal
vacA gene of H. pylori
To introduce in-frame internal deletion mutations into a
plasmid encoding VacA, we performed inverse PCR
using pMM592 (encoding wild-type VacA, amino acids
1 to 821) [33] as template DNA, 5’-phosphorylated pri-
mers, and Pfu Turbo polymerase (Stratagene). The
resulting PCR products were then ligated and trans-
formed into E. coli DH5a. Each plasmid was analyzed
by DNA sequencing to verify that the desired deletion
was present. To introduce the mutations into the H.
pylori chromosomal vacA gene [25,34,35], H. pylori
strains containing a sacB-kanamycin cassette within
vacA [36] were transformed with plasmids containing
vacA deletion mutations. Three strains (VM025,
VM018, and VM028), each derived from H. pylori strain
60190 and each containing the sacB-kanamycin cassette
in a different site within vacA [36], were used to facili-
tate construction of the desired mutants. Sucrose-resis-
tant, kanamycin-sensitive transformants were selected by
growth on Brucella broth plates supplemented with 10%
FBS and 5.5% sucrose [36]. Full-length vacA sequences
encoding the secreted p88 VacA protein were PCR-
a m p l i f i e df r o mm u t a n ts t r a i n s ,a n dt h en u c l e o t i d e
sequences of PCR products were analyzed to confirm
that the desired mutation had been introduced success-
fully into the chromosomal vacA gene.
Immunoblot analysis of VacA
To detect VacA expression, proteins in individual sam-
ples were separated by SDS-polyacrylamide gel electro-
phoresis, transferred to nitrocellulose membrane, and
immunoblotted using a polyclonal rabbit anti-VacA
antiserum (#958) raised against the secreted 88 kDa pas-
senger domain [37], followed by horseradish peroxidase-
l a b e l e dr a b b i tI g G .P e p t i d emapping experiments, using
a set of overlapping 16-amino-acid peptides derived
from VacA, indicate that the polyclonal anti-VacA anti-
serum #958 reacts with at least 10 different epitopes dis-
tributed throughout the secreted 88 kDa VacA protein,
including the amino-terminus (amino acids 1-16) and
the carboxy-terminus (amino acids 813-828) (our
unpublished data). To confirm similar loading of lysates
from wild-type and mutant H. pylori strains, the lysates
were immunoblotted with rabbit antiserum to HspB (a
GroEL heat shock protein homolog) [38]. The anti-
HspB serum was also used to detect the potential
release of HspB into culture supernatant by autolysis.
Signals were generated by the enhanced chemilumines-
cence reaction and detected using x-ray film.
Preparation of broth culture supernatants and
normalization of VacA concentrations
H. pylori strains were grown in BB-FBS for 48 hours.
Broth culture supernatants were concentrated 30-fold by
ultrafiltration with a 30 kDa cutoff membrane. Relative
concentrations of VacA in different broth culture super-
natant preparations were determined by antigen-detec-
tion ELISA [36]. Broth culture supernatants were
diluted in carbonate buffer (18 mM Na2CO3, 34.8 mM
NaHCO3) and allowed to adhere to an ELISA plate
overnight at room temperature. After removal of
unbound VacA proteins, wells were blocked with phos-
phate buffered saline (PBS) containing 3% BSA and
0.05% Tween 20. VacA was detected with rabbit anti-
VacA antiserum (#958) and horseradish peroxidase-
labeled rabbit IgG followed by TMB substrate (Pierce).
To permit normalization of VacA concentrations in dif-
ferent preparations, samples were diluted with
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vacA null mutant strain, based on the antigen-detection
ELISA results.
Sonication of H. pylori
H. pylori grown on blood agar plates were suspended in
sonication buffer [20 mM Tris-acetate (pH 7.9), 50 mM
potassium acetate, 5 mM Na2EDTA, 1 mM dithiothrei-
tol (DTT), protease inhibitor cocktail] and sonicated on
i c ef o rt h r e e1 0s e c o n dp u l s e s .T h el y s a t ew a sc e n t r i -
fuged at 15,000 rpm and the supernatant collected.
Susceptibility of VacA to proteolysis by trypsin
H. pylori grown on blood agar plates were suspended in
phosphate buffered saline (PBS), and bacterial suspen-
sions were treated with trypsin (0.05%) for 30 min at 37°
C. After addition of a protease inhibitor cocktail, the
bacteria were pelleted, and the pellet washed once with
PBS containing protease inhibitor. The pellet was then
suspended in SDS lysis buffer, boiled, and analyzed by
immunoblot. Sonicated preparations of H. pylori were
treated with trypsin and analyzed in the same manner.
Analysis of VacA reactivity with a monoclonal antibody
Concentrated culture supernatants containing different
VacA mutant proteins were adjusted so that the VacA
concentrations were normalized, and then were diluted
in carbonate buffer and allowed to adhere to an ELISA
plate overnight at room temperature. After removal of
unbound VacA proteins, wells were blocked with phos-
phate buffered saline (PBS) containing 3% BSA and
0.05% Tween 20. VacA was detected with mouse anti-
VacA (5E4) [35] and horseradish peroxidase-labeled
mouse IgG followed by TMB substrate (Pierce).
Cell culture analysis of VacA proteins
HeLa cells were grown as described previously [22]. AZ-
521 cells (a human gastric adenocarcinoma cell line,
Culture Collection of Health Science Research
Resources Bank, Japan Health Sciences Foundation) and
RK13 cells (ATCC CCL-37, a rabbit kidney cell line)
were grown in minimal essential medium supplemented
with 10% FBS and 1 mM non-essential amino acids. For
vacuolating assays, cells were seeded at 2 × 10
4 cells/
well into 96-well plates 24 hours prior to each experi-
ment. The VacA content of different samples was nor-
malized as described above. Serial dilutions of samples
were added to serum-free tissue culture medium overly-
ing cells (supplemented with 5 mM ammonium chlor-
ide) and incubated for 8-10 hours at 37°C. An
equivalent volume of a corresponding preparation from
a vacA null mutant was used as a negative control.
After incubation, cell vacuolation was examined by
inverted light microscopy and quantified by a neutral
red uptake assay [39]. Neutral red uptake data are pre-
sented as A540 values (mean ± S.D.). Background levels
of neutral red uptake by cells treated with culture super-
natant from a vacA null mutant were subtracted to yield
net neutral red uptake values.
Results
Expression and secretion of mutant VacA proteins by H.
pylori
The structure of the VacA p55 domain is dominated by
b-helical coils [3]. In previous studies, it has been diffi-
cult to identify specific amino acids within the p55
domain that are important for toxin activity [26]. To
determine whether specific b-helical elements within the
VacA p55 domain are required for VacA activity, we
introduced an ordered series of eight deletion mutations,
each 20 to 28 amino acids in length, into a portion of
the vacA gene that encodes the p55 domain. These dele-
tion mutations were designed so that each would result
in the deletion of a single coil of the b-helix (Fig. 1A;
representative single coils are highlighted in Fig. 1B). By
designing the deletion mutations in this manner, it was
predicted that the mutant proteins would exhibit reduc-
tions in the length of the b-helical region but would
exhibit minimal changes in protein folding in compari-
son to the wild-type VacA protein. All of the deletion
mutations analyzed in this study are located outside of
the VacA region (amino acids 1-422) previously found
to be required for cell vacuolation when VacA is
expressed in transiently transfected cells [24]. Each of
the mutations was introduced into the H. pylori chro-
mosomal vacA gene by natural transformation and alle-
lic exchange as described in Methods.
Each mutant H. pylori strain was tested by immuno-
blot analysis for the capacity to express VacA. We first
analyzed expression of the mutant strains grown on
blood agar plates. Each mutant strain expressed a VacA
protein with a mass of ~85 kDa (corresponding to the
VacA passenger domain), which indicated that in each
case, the ~140 kDa VacA protoxin underwent proteoly-
tic processing similar to wild-type VacA (data not
shown). We next analyzed expression and secretion of
V a c Aw h e nt h eb a c t e r i aw e r eg r o w ni nb r o t hc u l t u r e .
Wild-type H. pylori and each of the mutant strains
exhibited similar patterns of growth. Immunoblot analy-
sis of the bacterial cell pellets indicated that, as
expected, each of the mutant strains expressed an ~85
kDa VacA protein (Fig. 2A). In comparison to wild-type
VacA, several of the mutant VacA proteins were present
in reduced amounts in the bacterial cell pellets (Fig. 2A
and 2B). Immunoblot analysis of the broth culture
supernatants indicated that each of the mutant strains
secreted or released an ~85 kDa VacA protein. In com-
parison to secretion of VacA by the wild-type strain,
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moderately reduced levels, and three mutant proteins
(VacA Δ559-579, Δ580-607, and Δ608-628) were nearly
undetectable in culture supernatant (Fig. 2C and 2D).
Analysis of the culture supernatants by ELISA yielded
similar results (data not shown). Thus, all eight of the
mutant proteins were expressed and underwent proteo-
lytic processing similar to that of wild-type VacA, but
there was substantial variation among the mutant pro-
teins in the levels of expression and secretion.
Susceptibility of VacA mutant proteins to proteolytic
cleavage by trypsin
Previous studies have shown that the wild-type 88 kDa
VacA passenger domain is secreted and released into the
extracellular space and that 88 kDa proteins also remain
localized on the surface of H. pylori [ 4 0 ] .T oi n v e s t i g a t e
whether the mutant VacA proteins were able to localize
on the bacterial surface similar to wild-type VacA, the
wild-type and mutant H. pylori strains were harvested
from blood agar plates and treated with trypsin as
described in Methods. Trypsin is expected to proteolyti-
cally cleave proteins on the surface of the bacteria, but
not intracellular proteins [7]. Each of the ~85 kDa
mutant proteins was cleaved by trypsin (Fig. 3A), which
provided evidence that these mutant VacA proteins are
transported across the inner and outer membranes and
localize on the surface of the bacteria.
To analyze potential differences in folding properties of
the VacA mutant proteins compared to wild-type VacA,
we analyzed the susceptibility of these proteins to proteo-
lytic cleavage. Lysates of H. pylori strains were generated
by sonication, and the solubilized proteins were treated
with trypsin as described in Methods. Trypsin digestion
of two of the mutant proteins (Δ511-536 and Δ517-544)
yielded proteolytic digest patterns that were identical to
each other and similar to that of trypsin-digested wild-
type VacA (Fig. 3B). Trypsin digestion of two other
mutant proteins (Δ433-461 and Δ484-504) yielded differ-
ent digest patterns, but these mutant proteins were not
completely degraded (Fig. 3B). Four mutant proteins
(Δ462-483, Δ559-579, Δ580-607, and Δ608-628) were
completely degraded by trypsin (Fig. 3B). In general, the
four mutant proteins that exhibited relative resistance to
trypsin digestion were secreted at relatively high levels
compared to mutant proteins that were completely
degraded by trypsin (compare Fig. 2 and Fig. 3B). The
observed variation among mutant VacA proteins in sus-
ceptibility to trypsin-mediated proteolysis suggested that
the individual mutant proteins differed in folding
Figure 2 Expression and secretion of wild-type and mutant VacA proteins. H. pylori wild- type strain 60190, strains expressing mutant forms
of VacA, and a vacA null mutant strain (VM018) [36] were grown in broth culture. Broth cultures were normalized by optical density (OD 600 nm)
and then pellets (A) and unconcentrated broth culture supernatants (C) were analyzed by immunoblot assay using polyclonal anti-VacA serum
#958. Samples were also immunoblotted with a control antiserum against H. pylori heat shock protein (HspB). The intensity of immunoreactive
VacA bands was quantified by densitometry (panels B and D). Wild-type VacA and each of the mutant proteins were expressed and
proteolytically processed to yield ~85-88 kDa proteins that were secreted into the broth culture supernatant. Western blots depict representative
results from one of three independent experiments; histograms represent results pooled from three independent experiments. Results represent
the mean ± SD. *, p < 0.05 compared to wild-type VacA, as determined by Student’s t-test.
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trypsin digestion and secreted at very low levels (Δ462-
483, Δ559-579, Δ580-607, and Δ608-628) were probably
misfolded. Due to the very low concentrations of these
four proteins in the broth culture supernatants, these
mutant VacA proteins were not studied further.
To evaluate whether the four mutant proteins exhibit-
ing relative resistance to trypsin-mediated proteolysis (i.e.
VacA Δ433-461, Δ484-504, Δ511-536, and Δ517-544)
shared other features with wild-type VacA, we analyzed
the reactivity of these proteins with an anti-VacA mono-
clonal antibody (5E4) that recognizes a conformational
epitope [35]. Each of the four mutant VacA proteins was
recognized by the 5E4 antibody (Fig. 4), which provided
additional evidence that these mutant proteins were
folded in a manner similar to that of wild-type VacA.
Analysis of vacuolating activity of mutant VacA proteins
We next investigated whether the mutant VacA proteins
retained vacuolating toxin activity. As a first approach,
we attempted to purify the mutant VacA proteins from
H. pylori broth culture supernatants, using methods that
are well-established for purification of water-soluble oli-
gomeric forms of wild-type VacA or mutant VacA pro-
teins that contain alterations in the p33 domain
[26,34,36]. We focused these purification efforts on the
four mutant proteins that were secreted at the highest
levels and that exhibited evidence of protein folding
similar to that of wild-type VacA (i.e. VacA Δ433-461,
Δ484-504, Δ511-536, and Δ517-544). The yields of puri-
fied mutant proteins were markedly lower than yields of
purified wild-type VacA, and several of the VacA
mutant proteins were not successfully purified. These
results could be attributable to relative defects in oligo-
merization of mutant proteins compared to wild-type
VacA, or could be attributable to other altered proper-
ties of the mutant proteins that resulted in aberrant
behavior during the purification procedure.
Since it was not possible to purify sufficient quantities
of the mutant VacA proteins to permit analysis of
Figure 3 Susceptibility of VacA proteins to proteolytic cleavage by trypsin.A )I n t a c tH. pylori strains [wild-type strain 60190, strains
expressing mutant forms of VacA, and a vacA null mutant strain (VM018)] were suspended in PBS and incubated in the presence (+) or absence
(-) of trypsin as described in Methods. After centrifugation, bacterial pellets were analyzed by immunoblot analysis using polyclonal anti-VacA
serum #958. (B) H. pylori strains were sonicated as described in Methods. After centrifugation, the soluble fractions were analyzed further. The
total protein concentration of each sample was approximately 7.5 μg/ml, as determined by A280 values (data not shown). Samples were
incubated in the presence (+) or absence (-) of trypsin and analyzed by immunoblot analysis using polyclonal anti-VacA serum #958.
Figure 4 Reactivity of VacA mutant proteins with a monoclonal
anti-VacA antibody. Wild-type H. pylori strain 60190 and strains
expressing mutant VacA proteins were grown in broth culture, and
secreted VacA proteins were normalized as described in Methods.
Wells of ELISA plates were coated with broth culture supernatants,
and reactivity of the proteins with an anti-VacA monoclonal
antibody (5E4) that recognizes a conformational epitope was
determined by ELISA. Reactivity of a vacA null mutant was
subtracted as background. Relative VacA concentrations are
indicated. Values represent the mean ± SD from triplicate samples.
Ivie et al. BMC Microbiology 2010, 10:60
http://www.biomedcentral.com/1471-2180/10/60
Page 6 of 10vacuolating toxin activity, we used an alternative
approach. H. pylori culture supernatants containing
wild-type VacA or mutant proteins were normalized by
ELISA so that the VacA concentrations were similar, as
described in Methods, and then were tested for vacuo-
lating toxin activity. Using this approach, it was possible
to test the activity of the four mutant proteins that were
secreted at the highest levels and that exhibited evidence
of protein folding similar to that of wild-type VacA (i.e.
VacA Δ433-461, Δ484-504, Δ511-536, and Δ517-544),
but analysis of the remaining VacA mutant proteins
(which exhibited evidence of defective folding) was not
possible due to prohibitively low concentrations of the
secreted mutant proteins and inability to normalize the
concentrations of these proteins. The mutant proteins
were initially tested for ability to induce vacuolation of
HeLa cells, a cell line that is commonly used for the
study of VacA activity. Each of the mutant proteins
(VacA Δ433-461, Δ484-504, Δ511-536, and Δ517-544)
induced vacuolation of HeLa cells (Fig. 5A), but one of
the mutants, VacA Δ433-461, exhibited reduced vacuo-
lating activity compared to wild-type VacA. The same
preparations of mutant proteins were then tested for
their ability to induce vacuolation of AZ-521 cells
(human gastric epithelial cells) and RK13 cells (rabbit
kidney cells), two cells lines that have been used for
analysis of VacA activity [41-43]. VacA Δ484-504, Δ511-
536, and Δ517-544 each caused vacuolation of RK13
and AZ-521 cells, but VacA Δ433-461 lacked detectable
vacuolating activity for both RK13 and AZ-521 cells
(Fig. 5B and 5C). Thus, three of mutant proteins caused
vacuolation of all the tested cell lines in a manner simi-
lar to wild-type VacA, whereas VacA Δ433-461 caused
reduced vacuolation of HeLa cells and did not cause
detectable vacuolation of RK13 or AZ-521 cells. These
data suggest that residues within the region spanning
amino acids 433 to 461 contribute to VacA activity, and
indicate that the b-helical coils corresponding to amino
acids 484-504, 511-536 and 517-544 are dispensable for
vacuolating toxin activity.
Discussion
In this study, we sought to identify regions of the p55 b-
helix that are either essential or non-essential for vacuo-
lating toxin activity. All of the VacA mutant proteins
analyzed in this study were designed in a manner that
resulted in the deletion of a single coil of the b-helix,
based on analysis of the crystal structure of the VacA
p55 domain [3]. We predicted that all of the mutant
VacA proteins would retain a b-helical structure, and
that this mutagenesis approach would result in minimal
disruptions in protein folding.
As a first step, we analyzed the proteolytic processing
and secretion of the mutant proteins. All eight of the
mutant VacA proteins were expressed by the correspond-
ing H. pylori mutant strains and underwent proteolytic
processing to yield ~85 kDa passenger domains. We
found that several individual coils within the p55 domain
could be deleted without substantially altering the capa-
city of the proteins to undergo secretion by H. pylori.I n
contrast, the deletion of other coils led to a marked
defect in VacA secretion. The mutant proteins that
exhibited marked defects in secretion also exhibited
Figure 5 Vacuolating cytotoxic activity of mutant proteins.
Wild-type H. pylori strain 60190 and strains expressing mutant VacA
proteins were grown in broth culture, and secreted VacA proteins
were normalized as described in Methods. Serial two-fold dilutions
of VacA-containing preparations were added to HeLa cells (A), RK13
cells (B), and AZ-521 cells (C). Vacuolating activity was measured by
neutral red uptake. Relative VacA concentrations are indicated.
Results represent the mean ± SD from triplicate samples, expressed
as a percent of neutral red uptake induced by wild-type VacA. *, p
≤ 0.02 as determined by Student’s t-test compared to wild type
VacA. Similar results were observed in three independent
experiments.
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which suggested that these proteins were misfolded. In
addition to the mutant VacA proteins shown in Figure 1,
we also generated H. pylori mutant strains expressing
VacA proteins in which two coils (Δ433-483) or four
coils (Δ433-529) of the b-helix were deleted. These
mutant strains expressed truncated VacA proteins of the
expected size (approximately 82 and 77 kDa, respectively)
at levels similar to the level of wild-type VacA expression,
but these mutant proteins were poorly secreted (data not
shown). These findings suggest that VacA proteins con-
taining large deletions (more than one coil) within the b-
helical region of the p55 domain are poorly secreted.
Similarly, a previous study reported efforts to introduce
large deletions into the region of the H. pylori chromoso-
mal vacA gene that encodes the VacA p55 domain, and
most of the resulting mutant proteins were neither
expressed nor secreted by H. pylori [36].
In the current study, the three mutant VacA proteins
that exhibited the most striking defects in secretion
(Δ559-579, Δ580-607, Δ608-628) each contained deletions
that are localized near the carboxy-terminus of the b-
helix. Interestingly, a study of Bordetella pertussis BrkA
revealed that a b-helical region near the carboxy-terminus
of the passenger domain is required for folding of this pro-
tein [44]. The authors proposed that this domain acts as
an intramolecular chaperone to promote folding of the
passenger domain concurrent with or following transloca-
tion through the outer membrane. Similarly, studies of B.
pertussis pertactin indicate that the carboxy-terminal b-
helical region of this protein exhibits enhanced stability
and can fold as a stable core structure [5,45]. We speculate
that VacA amino acids 559-628 have a similar functional
role in promoting protein folding and secretion.
An important finding in the current study is that,
within the VacA b-helix, there are regions of plasticity
that tolerate alterations without detrimental effects on
protein secretion or toxin activity. VacA Δ484-504,
Δ511-536, and Δ517-544 mutant proteins each retained
vacuolating activity similar to that of wild-type VacA,
which indicates that the corresponding coils are dispen-
sable for vacuolating toxin activity. The retention of
vacuolating activity despite the deletion of entire coils of
the b-helix correlates well with results from a previous
study, which reported that inactivating point mutations
within the portion of vacA encoding the p55 domain
could not be identified [26]. One of the VacA mutant
proteins analyzed in the current study (Δ433-461) exhib-
ited detectable vacuolating toxin activity on HeLa cells,
but its activity on HeLa cells was reduced compared to
that of wild-type VacA, and it lacked detectable activity
on RK13 cells and AZ521 cells. These data suggest that
residues within this VacA region (amino acids 433-461)
have an important role in VacA activity. Further studies
may lead to the identification of specific amino acids
within this region that mediate interactions between
VacA and host cells. Similar to most previous studies,
the current study assessed the effects of VacA mutations
on the ability of VacA to cause cell vacuolation. Future
investigations may provide new insights into structural
properties of VacA that are required for other actions of
this multifunctional toxin.
Conclusions
VacA is a unique toxin that is considered to be an impor-
tant determinant of H. pylori virulence, and therefore, it
is important to have an in-depth understanding of VacA
structure and function. The VacA p55 structure is predo-
minantly a right-handed parallel b-helix, which is a char-
acteristic of autotransporter passenger domains. Previous
studies suggested that the p55 domain contributes to
VacA binding to cells, but it has been difficult to identify
small inactivating mutations within the p55 domain.
Therefore, we hypothesized that large segments of the
p55 domain might be non-essential for vacuolating toxin
activity. To test this hypothesis, we constructed and ana-
lyzed a set of H. pylori mutant strains expressing VacA
proteins in which individual coils of the beta-helix were
deleted. Three mutant proteins containing deletions in
the region spanning VacA amino acids 484-544 were effi-
ciently secreted and induced vacuolation of mammalian
cells, which indicates that these segments are dispensable
for vacuolating toxin activity. We also identified a region
near the carboxy-terminal end of the b-helix (amino
acids 559-628), in which the introduction of similar dele-
tion mutations resulted in marked defects in protein
secretion and apparent defects in protein folding. We
propose that non-essential b-helical coils and a carboxy-
terminal b-helical segment required for proper protein
folding and secretion are features of numerous autotran-
sporter passenger domains.
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